Clinical Trial Update: Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update for Xalacom and a fixed unfixed combination of latanoprost and timolol in open-angle glaucoma or ocular hypertension; trial status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• Xalacom (latanoprost/timolol)
• latanoprost/timolol fixed combination (latanoprost/timolol)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma, Open Angle, Ocular Hypertension | Phase 3 | Status: COMPLETED